HDR Gateway logo
HDR Gateway logo

Bookmarks

PHOENIX DDR-Anti-PD-L1 Trial

Population Size

Not reported

Years

2019

Associated BioSamples

Availability to be confirmed

Geographic coverage

United Kingdom

England

Lead time

Other

Summary

Collection of samples and data across the following diseases: Malignant tumour of breast.

Documentation

PHOENIX DDR/Anti-PD-L1 Trial: A pre-surgical window of opportunity and post-surgical adjuvant biomarker study of DNA damage response inhibition and/or anti-PD-L1 immunotherapy in patients with neoadjuvant chemotherapy resistant residual triple negative breast cancer.
Dataset type
Health and disease
Dataset sub-type
Not applicable

Keywords

PHOENIX DDR, Anti-PD-L1 Trial, Malignant tumour of breast, UKCRC Tissue Directory

Provenance

Image contrast
Not stated
Biological sample availability
Availability to be confirmed

Details

Publishing frequency
Other
Version
1.0.0
Modified

08/10/2024

Distribution release date

17/08/2018

Citation Requirements
In Progress

Coverage

Start date

01/01/2019

Time lag
Variable
Geographic coverage
United Kingdom, England

Accessibility

Language
en
Controlled vocabulary
LOCAL
Format
In Progress

Data Access Request

Dataset pipeline status
Not available
Access rights
Please contact the publisher using Contact Point details provided.
Time to dataset access
Other
Access request cost
Not specified
Access method category
Varies based on project
Data Controller
The Institute of Cancer Research

Dataset Types: Health and disease


Collection Sources: